Nano Giovanni, Dalainas Ilias, Bianchi Paolo, Ciarmoli Elena, Malacrida Giovanni, Ramponi Fabio, Tealdi Domenico G
Unità Operativa di Chirurgia Vascolare, Policlinico San Donato - IRCCS, Scuola di Chirurgia Vascolare Università degli studi di Milano.
Ann Ital Chir. 2007 Mar-Apr;78(2):149-52.
The aim of this single-institution retrospective study is to report the results of surgical and endovascular treatment of hepatic artery aneurysms.
Twenty patients with an extraparenchimal hepatic artery aneurysm made part of the study In the first period, between February 1980 and December 1996, 12 patients were admitted and treated surgically. In the second period, January 1997 until December 2005, 8 patients were admitted. Four were treated surgically and 4 with an endovascular procedure. The aneurysms ranged from 2.3 cm to 6.2 cm Seventeen patients were asymptomatic, while three were symptomatic for pain and obstructive icterus. In 13 patients aneurysmectomy and graft interposition was performed, in three patients aneurysmectomy with dacron patch interposition was performed, and in 4 patients the aneurysm was excluded with a stent-graft.
No perioperative mortality was noted and no major complication occurred. All endovascular procedures successfully excluded the aneurysm without signs of endoleak. Follow-up in 4 months, 6 months and 10 months postoperatively showed patency of the stent-graft with no signs of migration or endoleak. Only in one case, in the 8th post-operative month, thrombosis of the stent-graft occurred and the patient was completely asymptomatic.
The natural history of hepatic artery aneurysms is rupture, and consequently there is an indication of treatment. Actually, we consider endovascular treatment as the first-choice-treatment whenever possible. Endovascularlly treated patients need a strict follow-up surveillance by imaging means. Particular attention so be given in the preoperative study of the collateral circulation in patient treated surgically.
本单机构回顾性研究旨在报告肝动脉瘤的手术及血管内治疗结果。
20例肝实质外肝动脉瘤患者纳入本研究。第一阶段,1980年2月至1996年12月,收治12例患者并进行手术治疗。第二阶段,1997年1月至2005年12月,收治8例患者。4例行手术治疗,4例行血管内治疗。动脉瘤大小在2.3厘米至6.2厘米之间。17例患者无症状,3例有疼痛和梗阻性黄疸症状。13例患者行动脉瘤切除术并植入移植物,3例患者行动脉瘤切除术并植入涤纶补片,4例患者用支架移植物隔绝动脉瘤。
未观察到围手术期死亡,未发生重大并发症。所有血管内治疗均成功隔绝动脉瘤,无内漏迹象。术后4个月、6个月和10个月随访显示支架移植物通畅,无移位或内漏迹象。仅1例患者在术后第8个月出现支架移植物血栓形成,但患者完全无症状。
肝动脉瘤的自然病程是破裂,因此有治疗指征。实际上,我们尽可能将血管内治疗作为首选治疗方法。接受血管内治疗的患者需要通过影像学手段进行严格的随访监测。对于接受手术治疗的患者,术前对侧支循环的研究应给予特别关注。